Photo of Prof Andrew Pettitt

Prof Andrew Pettitt MA, MB BChir, PhD, MRCP, FRCPath

Ronald Finn Professor of Experimental Medicine and Honorary Consultant Haematologist (Clatterbridge Cancer Centre) Molecular and Clinical Cancer Medicine

About

Personal Statement

Andrew studied Medicine at Cambridge (1983-1989) before taking up clinical training posts in Internal Medicine (Nottingham, 1990-1992) and Haematology (Liverpool, 1992-2000) during which time he completed a PhD. He was appointed as a Clinical Senior Lecturer in Liverpool in 2000, with subsequent promotion to Reader (2004) and Personal Chair (2006) and designation as the inaugural Ronald Finn Professor of Experimental Medicine (2013). Andrew’s local leadership roles include being Head of the University Department of Molecular and Clinical Cancer Medicine (from 2011), Chair of the University’s Clinical Trials Oversight Committee (from 2018) and Cancer Programme Lead for Liverpool Health Partners (from 2019). At national level, Andrew was appointed as Chair of the National Cancer Research Institute (NCRI) Lymphoma Clinical Studies Group (CSG) in 2017, having previously chaired the NCRI Haematological Oncology CSG (2012-2017) and UK CLL Forum (2006-2012).